healthcare-market-research

[healthcare-market-research]

Retinitis Pigmentosa (RP) Treatment Outlook in the MENA

As per NORD, Retinitis Pigmentosa (RP) affects nearly 1 in 3,000–1 in 4,000 people worldwide. In regions like the United Arab Emirates (UAE), Saudi Arabia, Kuwait, and others, the disease is more prominent affecting nearly about two and half times of other countries like the US and Europe mainly due to consanguineous marriages.

Currently, the Retinitis Pigmentosa Treatment Market for all forms of RP is revolving around off-label therapies like nutritional supplements and supportive measures. To provide an effective therapeutic option, globally some of the key companies are conducting clinical trials which have shown promising results.

Read More: Retinitis Pigmentosa (RP) Treatment Outlook in the MENA

[healthcare-market-research]

Cancer Diagnosis and Treatment Developments in the MENA Region

Globally, cancer is a major health problem, leading to a high number of deaths every year. The scenario is not different in the Middle East and North Africa (MENA) region. As per the estimates, the numbers of new lung cancer cases in the MENA region in 2018 were 79,887, with a 5-year relative survival rate of just 8%. Similarly, the incidence of breast cancer in 2016 among women in the Arab region was found to be 28/100,000.

To overcome the challenges in Breast Cancer and Lung Cancer, several global pharma giants such as Eli Lilly and Company, AbbVie, AstraZeneca, Merck, and Novartis are diligently working towards the development of new therapies. The ongoing clinical trials for lung and breast cancers therapies states promising treatment outcome in the coming years. 

Read More: Cancer Diagnosis and Treatment Developments in the MENA Region

[healthcare-market-research]

Atopic Dermatitis: Examining the Expanding Therapeutic Pipeline in the MENA Region

As per the estimates, the prevalence of Atopic Dermatitis in regions of the Middle East and North Africa (MENA) has generally been lower than in Europe and North America – the reported prevalence amongst the countries in the region ranges from 3 to 14%. However, in recent times trends show increasing AD prevalence in the developing world, including the MENA region. 

The emerging pipeline for AD in the MENA region is dry. Currently, some of the key players such as  Eli Lilly and Company, Shulov Innovate for Science, AbbVie, Pfizer, and others, are diligently working on developing new therapies for Atopic Dermatitis. The launch of the therapies is expected to improve the treatment scenario in the coming years.

Read More:Atopic Dermatitis in the MENA Region

[healthcare-market-research]

Orphan Drugs in the MENA region

As per the estimates, nearly 2.8 million people are affected by rare diseases in the MENA region. More than 900 rare diseases, including Gaucher disease, Fabry disease, thalassemia, sickle cell disease, etc. are reported in the regional countries. The prevalence rate of rare diseases in the MENA region is high due to consanguineous marriages.

There are several challenges in the healthcare system related to the availability of orphan drugs across the MENA region. Some of the factors such as the high price of orphan drugs, lengthy approval process, logistical challenges, and complex geopolitical situations in some countries affect the Orphan drug’s availability to the affected population. To overcome these challenges, the governments are looking forward to formulating policies and improving access.

Read More:Orphan Drugs in the MENA region

[healthcare-market-research]

GCC MedTech Industry Outlook

The impact of COVID-19 on the MedTech industry in GCC was massive. To improve the MedTech industry outlook within the GCC region and to facilitate the speedy delivery of medical devices, government bodies and regulators have improvised registration, procurement, & import processes and also liberalized restrictions on several medical devices including kits and PPEs. 

Similarly, to address the situation, the MedTech companies are also using innovative strategies including optimization in supply chains, increase in investments for upcoming MedTech options, and geographical diversification (increasing presence in several regions). Along with these measures, government and MedTech companies are looking forward to working in collaboration to increase the manufacturing capacity of the medical devices locally, thereby improving the overall scenario of the MedTech industry in the coming years.

Learn More: GCC MedTech Industry Outlook 

[healthcare-market-research]

MENA Healthcare Market: Opportunities and Challenges

Over the past few years, healthcare spending has risen significantly in the Middle East and North Africa (MENA) region. Currently, more than 140 companies operating in the MENA region’s pharma market. Due to strong demand and supply considerations, globally, several pharmaceutical and biotech companies are expected to enter the healthcare market..  

Owing to various factors such as favorable government policies, evolving health insurance segment, and a growing propensity among the local population to consume digital health services, rise in the income levels,  increase in the geriatric population,  increased health awareness, improvement in life expectancy, lifestyle changes, the MENA Healthcare Market is expected to witness an upsurge in the market growth in the coming years.

Read More: MENA Healthcare Market: Opportunities and Challenges

[healthcare-market-research]

Retinitis Pigmentosa (RP) Management in the MENA

As per NORD, Retinitis Pigmentosa (RP) affects nearly 1 in 3,000–1 in 4,000 people worldwide. In regions like the United Arab Emirates (UAE), Saudi Arabia, Kuwait, and others, the disease is more prominent affecting nearly about two and half times of other countries like the US and Europe mainly due to consanguineous marriages.

Currently, the Retinitis Pigmentosa Treatment Market for all forms of RP is revolving around off-label therapies like nutritional supplements and supportive measures. To provide an effective therapeutics option, globally some of the key companies are conducting clinical trials which has shown promising result.

Due to high unmnet need and to bridge the treatmnet gap, globally some of the key companies are conducting clinical trials. The major markets like the US and EU are showing great promise in terms of clinical trials. Yet, not much development for newer therapies is visible in the MENA region. However, in the coming years the treatment outlook is expected to improve due to higher prevalence and the onoing R&D activities, the treatment scenario in the region is also expected to improve in the coming years.

For more detailed information, visit: Retinitis Pigmentosa (RP) Management in the MENA

[healthcare-market-research]

Cancer Diagnosis in the MENA Region

Globally, cancer is a major health problem, leading to a high number of deaths every year. The scenario is not different in the Middle East and North Africa (MENA) region. As per the estimates, the numbers of new lung cancer cases in the MENA region in 2018 were 79,887, with a 5-year relative survival rate of just 8%. Similarly, the incidence of breast cancer in 2016 among women in the Arab region was found to be 28/100,000.

To overcome the challenges in Breast Cancer and Lung Cancer, several global pharma giants such as Eli Lilly and Company, AbbVie, AstraZeneca, Merck and Novartis are diligently working towards the development of new therapies. The ongoing clinical trials for lung and breast cancers therapies states promising treatment outcome in the coming years.

For more details, visit: Cancer Diagnosis in the MENA Region 

[healthcare-market-research]

Competitive Intelligence and Consulting Services - DelveInsight

Consulting has been at the forefront of conceptualizing transformation, prioritizing #projects and updating vision for maintaining #competitiveadvantage in the #industry. DelveInsight works to collate and analyze internal and external factors to mitigate #risks and capture #opportunities to create a strong foundation for a winning #strategy. Through our consistent reporting and insightful #analytics, DelveInsight helps you restructure, sharpen and develop #strategies with our varied service offerings. Reach out to us to discuss your most critical issues so that we may aid you in developing new #opportunities. Get in touch with us: https://www.delveinsight.com/consulting or email us at info@delveinsight.com